Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Future Oncology (London, England)|February 7, 2007
Alemtuzumab in chronic lymphocytic leukemiaDanelle F James, Thomas J Kipps
Advances in Therapy|July 5, 2011
Rituximab in chronic lymphocytic leukemiaDanelle F James, Thomas J Kipps
European Journal of Haematology|February 18, 2011
Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemiaAnne Mette Buhl, Danelle F James, Donna Neuberg, et al.
Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.
Leukemia & Lymphoma|October 3, 2018
Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinibJacqueline C Barrientos, Jan A Burger, John C Byrd, et al.
Hematology (Amsterdam, Netherlands)|March 6, 2020
Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunctionJoi Ninomoto, Ahmad Mokatrin, Taisei Kinoshita, et al.
Annals of Hematology|September 3, 2014
Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinibDavid D Smith, Leanne Goldstein, Mei Cheng, et al.
Blood|March 11, 2015
The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemiaJennifer R Brown, Jacqueline C Barrientos, Paul M Barr, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemiaWeizhou Zhang, Arnon P Kater, George F Widhopf, et al.
Pageof 4